本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

TriSalus Life Sciences Inc.

4.41
-0.1500-3.29%
成交量:3.71万
成交额:16.62万
市值:2.20亿
市盈率:-3.73
高:4.60
开:4.50
低:4.36
收:4.56
52周最高:5.88
52周最低:3.42
股本:4,986.73万
流通股本:3,948.59万
量比:0.30
换手率:0.09%
股息:- -
股息率:- -
每股收益(TTM):-1.1835
每股收益(LYR):-1.3119
净资产收益率:-496.21%
总资产收益率:-52.51%
市净率:-11.32
市盈率(LYR):-3.36

数据加载中...

2023/12/15

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/14

SEC问询函

Form CORRESP - Correspondence
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/10/19

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/18

SEC问询函

Form CORRESP - Correspondence
2023/10/16

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/10/03

重要事件披露

Form 8-K - Current report
2023/09/02

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/31

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/08/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/23

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/21

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/08/21

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/08/21

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/21

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/08/21

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/16

重要事件披露

Form 8-K - Current report